-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Ayala Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q3 2011 to Q3 2022.
- Ayala Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending October 31, 2022 was $38.3M, a 16.1% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)